𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary central nervous system lymphoma in a patient treated with Natalizumab

✍ Scribed by Remy Phan-Ba; Bettina Bisig; Manuel Deprez; Bernard De Prijck; Gael Delrue; Christian Herens; Gustave Moonen; Shibeshih Belachew; Laurence de Leval


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
308 KB
Volume
69
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Primary central nervous system lymphoma
✍ Andreas Schweikert; Marcus Kremer; Florian Ringel; Thomas Liebig; Justus Duyster πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 1 views

## Abstract A 40‐year‐old man with relapsing‐remitting multiple sclerosis (MS) developed primary central nervous system lymphoma (PCNSL) after having received 21 doses of natalizumab monotherapy. PCNSL is a disease of the elderly, with the majority of patients being diagnosed in the 7th to 8th deca

Primary central nervous system lymphoma
✍ Lisa M. Deangelis πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 2 views

Primary central nervous system lymphoma (PCNSL) is a rare neoplasm, but it is occurring with increased frequency even among apparently immunocompetent patients. Although secondary malignancies frequently involve the lymphoreticular system, PCNSL has been reported as a second neoplasm only once previ